Search

Your search keyword '"Dreyer, L"' showing total 116 results

Search Constraints

Start Over You searched for: Author "Dreyer, L" Remove constraint Author: "Dreyer, L" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
116 results on '"Dreyer, L"'

Search Results

1. Buoy measurements of strong waves in ice amplitude modulation: a signature of complex physics governing waves in ice attenuation

3. OP0238-HPR EFFECTIVENESS OF A NOVEL DIGITAL PATIENT EDUCATION PROGRAMME TO SUPPORT SELF-MANAGEMENT OF EARLY RHEUMATOID ARTHRITIS: A RANDOMISED CONTROLLED TRIAL

5. POS0022 MORTALITY FROM INTERSTITIAL LUNG DISEASE IN RHEUMATOID ARTHRITIS – A COLLABORATIVE STUDY FROM THE NORDIC COUNTRIES

7. Incidence of seropositive and seronegative rheumatoid arthritis in Denmark: a nationwide population-based study.

8. Treatment-related changes in serum neutrophil gelatinase-associated lipocalin (NGAL) in psoriatic arthritis:results from the PIPA cohort study

11. Quantitative sensory testing, psychological profiles and clinical pain in patients with psoriatic arthritis and hand osteoarthritis experiencing pain of at least moderate intensity.

12. Treatment-related changes in serum neutrophil gelatinase-associated lipocalin (NGAL) in psoriatic arthritis: results from the PIPA cohort study.

15. OP0022 COMPARATIVE EFFECTIVENESS OF BIOLOGIC AND TARGETED SYNTHETIC DMARDS IN PSORIATIC ARTHRITIS ACCORDING TO COMORBIDITIES AT TREATMENT START: A NORDIC COLLABORATIVE STUDY BASED ON ENRICHED CLINICAL REGISTERS

16. OP0219 INCIDENCE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH JAK-INHIBITORS COMPARED TO BDMARDS: DATA FROM AN INTERNATIONAL COLLABORATION OF REGISTRIES (THE “JAK-POT” STUDY)

17. POS0248 EXPLORING TUMOUR NECROSIS FACTOR INHIBITOR DRUG LEVELS DURING DISEASE ACTIVITY-GUIDED TAPERING IN PATIENTS WITH INFLAMMATORY ARTHRITIS: SECONDARY ANALYSES FROM THE BIODOPT TRIAL

20. Predicting successful biologics tapering in patients with inflammatory arthritis: Secondary analyses based on the BIOlogical Dose OPTimisation (BIODOPT) trial

21. Treatment-related changes in serum neutrophil gelatinase-associated lipocalin (NGAL) in psoriatic arthritis: results from the PIPA cohort study

22. Disease activity-guided tapering of biologics in patients with inflammatory arthritis: a pragmatic, randomized, open-label, equivalence trial

24. Safe Vessel Operations – The Tacit Knowledge of Navigators.

37. OP0060 EXPOSURE TO SPECIFIC TUMOR NECROSIS FACTOR INHIBITORS AND RISK OF DEMYELINATING AND INFLAMMATORY NEUROPATHY IN PATIENTS WITH INFLAMMATORY ARTHRITIS. A COLLABORATIVE OBSERVATIONAL STUDY ACROSS FIVE NORDIC RHEUMATOLOGY REGISTERS

38. OP0257 RISK OF HAEMATOLOGICAL MALIGNANCY IN PATIENTS WITH PSORIATIC ARTHRITIS, OVERALL AND IN RELATION TO TNF INHIBITORS - A NORDIC COHORT STUDY

41. POS0076 DRUG SURVIVAL OF BIOLOGICS AND NOVEL IMMUNOMODULATORS FOR RHEUMATOID ARTHRITIS, AXIAL SPONDYLOARTHRITIS, PSORIATIC ARTHRITIS, AND PSORIASIS - A NATIONWIDE COHORT STUDY FROM THE DANBIO AND DERMBIO REGISTRIES

44. AB0006 ESTABLISHED RISK LOCI FOR SYSTEMIC LUPUS ERYTHEMATOSUS AT NCF2, STAT4, TNPO3, IRF5 AND ITGAM ASSOCIATE WITH DISTINCT CLINICAL MANIFESTATIONS: A DANISH GENOME-WIDE ASSOCIATION STUDY

45. Incidence and prevalence of rheumatoid arthritis in Denmark from 1998 to 2018: a nationwide register-based study.

46. Die gebruik van belonings om grondslagfaseleerders in spesiale skole se akademiese selfdoeltreffendheid en motivering te verhoog.

47. INCIDENCE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH JAK-INHIBITORS COMPARED TO BDMARDS: DATA FROM AN INTERNATIONAL COLLABORATION OF REGISTRIES (THE "JAK-POT" STUDY).

Catalog

Books, media, physical & digital resources